image
Healthcare - Medical - Care Facilities - NYSE - US
$ 7.35
-1.21 %
$ 370 M
Market Cap
-3.22
P/E
1. INTRINSIC VALUE

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families.[ Read More ]

The intrinsic value of one EHAB stock under the base case scenario is HIDDEN Compared to the current market price of 7.35 USD, Enhabit, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart EHAB

image
FINANCIALS
1.05 B REVENUE
-3.40%
-47.6 M OPERATING INCOME
-44.24%
-80.5 M NET INCOME
-124.61%
48.4 M OPERATING CASH FLOW
-39.58%
-5.3 M INVESTING CASH FLOW
87.47%
-40.5 M FINANCING CASH FLOW
-117.74%
254 M REVENUE
-2.69%
-98 M OPERATING INCOME
-875.00%
-108 M NET INCOME
-54000.00%
28.4 M OPERATING CASH FLOW
195.83%
-400 K INVESTING CASH FLOW
33.33%
-10.8 M FINANCING CASH FLOW
40.66%
Balance Sheet Decomposition Enhabit, Inc.
image
Current Assets 210 M
Cash & Short-Term Investments 27.4 M
Receivables 168 M
Other Current Assets 15 M
Non-Current Assets 1.22 B
Long-Term Investments 0
PP&E 76.5 M
Other Non-Current Assets 1.15 B
Current Liabilities 138 M
Accounts Payable 7.6 M
Short-Term Debt 46.1 M
Other Current Liabilities 84 M
Non-Current Liabilities 594 M
Long-Term Debt 573 M
Other Non-Current Liabilities 21.5 M
EFFICIENCY
Earnings Waterfall Enhabit, Inc.
image
Revenue 1.05 B
Cost Of Revenue 566 M
Gross Profit 480 M
Operating Expenses 442 M
Operating Income -47.6 M
Other Expenses 32.9 M
Net Income -80.5 M
RATIOS
45.86% GROSS MARGIN
45.86%
-4.55% OPERATING MARGIN
-4.55%
-7.69% NET MARGIN
-7.69%
-12.02% ROE
-12.02%
-5.62% ROA
-5.62%
-3.38% ROIC
-3.38%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Enhabit, Inc.
image
Net Income -80.5 M
Depreciation & Amortization 30.9 M
Capital Expenditures -3.5 M
Stock-Based Compensation 8.9 M
Change in Working Capital 11.7 M
Others 112 M
Free Cash Flow 44.9 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Enhabit, Inc.
image
Wall Street analysts predict an average 1-year price target for EHAB of $8.5 , with forecasts ranging from a low of $8.5 to a high of $8.5 .
EHAB Lowest Price Target Wall Street Target
8.5 USD 15.65%
EHAB Average Price Target Wall Street Target
8.5 USD 15.65%
EHAB Highest Price Target Wall Street Target
8.5 USD 15.65%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Enhabit, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
5.59 K USD 1
9-12 MONTHS
0 USD 0
Bought
117 K USD 1
0-3 MONTHS
142 K USD 1
3-6 MONTHS
100 K USD 2
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
5 days ago
Nov 12, 2024
Bought 22.8 K USD
Bolton Jeffrey
Director
+ 3000
7.6 USD
1 week ago
Nov 08, 2024
Bought 49.3 K USD
Bolton Jeffrey
Director
+ 6351
7.77 USD
1 week ago
Nov 08, 2024
Bought 5.03 K USD
Bolton Jeffrey
Director
+ 649
7.75 USD
2 months ago
Aug 22, 2024
Bought 40 K USD
Bolton Jeffrey
Director
+ 5000
8.01 USD
3 months ago
Aug 09, 2024
Bought 41.4 K USD
Bolton Jeffrey
Director
+ 5000
8.29 USD
3 months ago
Aug 08, 2024
Bought 17.2 K USD
Bolton Jeffrey
Director
+ 2000
8.6 USD
6 months ago
May 17, 2024
Bought 83.3 K USD
Bolton Jeffrey
Director
+ 10000
8.33 USD
6 months ago
May 14, 2024
Bought 18 K USD
Hoeflinger Erin
Director
+ 2000
9 USD
6 months ago
May 10, 2024
Bought 82.4 K USD
Bolton Jeffrey
Director
+ 10000
8.24 USD
8 months ago
Mar 01, 2024
Sell 5.59 K USD
Langham Ronald Leroy JR
EVP Clinical Excel. & Strategy
- 634
8.81 USD
1 year ago
May 26, 2023
Bought 23.2 K USD
Bolton Jeffrey
Director
+ 2000
11.61 USD
1 year ago
May 22, 2023
Bought 120 K USD
SHAW L EDWARD JR
Director
+ 10000
11.98 USD
1 year ago
May 18, 2023
Bought 24.8 K USD
Hoeflinger Erin
Director
+ 2100
11.82 USD
1 year ago
May 18, 2023
Bought 120 K USD
Langham Ronald Leroy JR
EVP Clinical Excel. & Strategy
+ 10000
11.99 USD
1 year ago
May 17, 2023
Bought 23.6 K USD
Bolton Jeffrey
Director
+ 2000
11.8 USD
2 years ago
Nov 18, 2022
Bought 12.7 K USD
Bolton Jeffrey
Director
+ 1000
12.69 USD
2 years ago
Nov 09, 2022
Bought 25.5 K USD
Bolton Jeffrey
Director
+ 2000
12.75 USD
2 years ago
Nov 08, 2022
Bought 25.8 K USD
Bolton Jeffrey
Director
+ 2000
12.89 USD
2 years ago
Nov 08, 2022
Bought 5.78 K USD
HIGDON LEO I JR
Director
+ 426
13.57 USD
2 years ago
Nov 07, 2022
Bought 105 K USD
Rush Gregory S
Director
+ 8300
12.69 USD
2 years ago
Nov 04, 2022
Bought 21.4 K USD
Rush Gregory S
Director
+ 1700
12.58 USD
2 years ago
Aug 31, 2022
Bought 24.8 K USD
Brown-Stevenson Tina L.
director:
+ 1550
15.99 USD
2 years ago
Aug 18, 2022
Bought 13.5 K USD
Hoeflinger Erin
director:
+ 970
13.9 USD
2 years ago
Aug 18, 2022
Bought 82.1 K USD
Hoeflinger Erin
Director
+ 6030
13.62 USD
2 years ago
Aug 17, 2022
Bought 25 K USD
Marion Tanya Renee
Chief Human Resources Officer
+ 1712
14.6 USD
2 years ago
Aug 11, 2022
Bought 50.1 K USD
ELSON CHARLES M
director:
+ 3700
13.55 USD
2 years ago
Aug 08, 2022
Bought 13.6 K USD
MAUPIN JOHN E JR D D S
director:
+ 1000
13.59 USD
2 years ago
Aug 08, 2022
Bought 20.6 K USD
CURL YVONNE M
director:
+ 1500
13.75 USD
2 years ago
Aug 09, 2022
Bought 413 K USD
Jacobsmeyer Barbara Ann
President and CEO
+ 30000
13.78 USD
2 years ago
Aug 09, 2022
Bought 136 K USD
SHAW L EDWARD JR
director:
+ 10000
13.64 USD
2 years ago
Aug 04, 2022
Bought 37.1 K USD
HIGDON LEO I JR
director:
+ 3000
12.37 USD
2 years ago
Aug 04, 2022
Bought 176 K USD
LaMonica Susan
director:
+ 15000
11.72 USD
2 years ago
Aug 04, 2022
Bought 11.7 K USD
Bolton Jeffrey
director:
+ 1000
11.74 USD
2 years ago
Aug 03, 2022
Bought 61.1 K USD
HIGDON LEO I JR
director:
+ 4500
13.57 USD
7. News
Enhabit, Inc. (EHAB) Q3 2024 Earnings Call Transcript Enhabit, Inc. (NYSE:EHAB ) Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ET Company Participants Jobie Williams – Senior Vice President and Treasurer Barb Jacobsmeyer – President and Chief Executive Officer Crissy Carlisle – Chief Financial Officer Conference Call Participants Brian Tanquilut – Jefferies A. J. Rice – UBS Ryan Langston – TD Cowen Operator Good morning, everyone and welcome to Enhabit's Home Health and Hospice's Third Quarter, 2024 Earnings Conference Call. seekingalpha.com - 1 week ago
Enhabit Home Health & Hospice Appoints Ryan Solomon as Chief Financial Officer DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), (“Enhabit”), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. M. businesswire.com - 1 week ago
Enhabit (EHAB) Misses Q3 Earnings and Revenue Estimates Enhabit (EHAB) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.03 per share a year ago. zacks.com - 1 week ago
Enhabit Reports Third Quarter 2024 Financial Results DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2024. “Our continued progress in our strategies during the third quarter resulted in Adjusted EBITDA growth year over year and strong free cash flow generation that led to further debt reduction,” said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. “The payor innovation strategy continues to fo. businesswire.com - 1 week ago
Enhabit Home Health & Hospice Recognized as an Age-Friendly Health Systems Participant DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its recognition by the Institute for Healthcare Improvement (IHI) as an Age-Friendly Health Systems Participant. Age-friendly Health Systems Participants are recognized for being on the journey to becoming an Age-Friendly Health System and have submitted a description of how they are putting four essential elements of care--the 4Ms--into practice with older patients. "We're participa. businesswire.com - 4 weeks ago
Enhabit Home Health & Hospice Announces Date of 2024 Third Quarter Earnings Call DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the third quarter ended Sept. 30, 2024, on Nov. 6, 2024, and host a webcast and conference call on Nov. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Nov. 7, 2024 10 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Inte. businesswire.com - 1 month ago
Vanguard Group Inc's Strategic Reduction in Enhabit Inc Shares On September 30, 2024, Vanguard Group Inc, a prominent investment firm, executed a significant transaction involving the shares of Enhabit Inc (EHAB, Financial). The firm reduced its holdings by 626,911 shares, which adjusted its total stake in the company to 2,976,480 shares. gurufocus.com - 1 month ago
Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 NEW YORK , Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. prnewswire.com - 2 months ago
Enhabit, Inc. (EHAB) Q2 2024 Earnings Call Transcript Enhabit, Inc. (NYSE:EHAB ) Q2 2024 Earnings Conference Call August 7, 2024 10:00 AM ET Company Participants Barb Jacobsmeyer - President & CEO Crissy Carlisle - CFO Conference Call Participants Noah Erni - Jefferies Ben Rossi - Citi A.J. Rice - UBS Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Operator Good morning, everyone, and welcome to Enhabit Home Health & Hospice's second quarter 2024 earnings conference call. seekingalpha.com - 3 months ago
Enhabit (EHAB) Q2 Earnings Surpass Estimates Enhabit (EHAB) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.04 per share a year ago. zacks.com - 3 months ago
Enhabit Announces CFO Transition DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities. Enhabit has initiated a comprehensive search to identify the Company's next chief financial officer. “Crissy has made important contributions to Enhabit since we became a public. businesswire.com - 3 months ago
Here Is Why Bargain Hunters Would Love Fast-paced Mover Enhabit (EHAB) Enhabit (EHAB) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen. zacks.com - 3 months ago
8. Profile Summary

Enhabit, Inc. EHAB

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 370 M
Dividend Yield 0.00%
Description Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
Contact 6688 N. Central Expressway, Dallas, TX, 75206 https://www.ehab.com
IPO Date June 23, 2022
Employees 10800
Officers Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T. President, Chief Executive Officer & Director Mr. Dylan C. Black General Counsel & Secretary Ms. Tanya R. Marion Chief Human Resources Officer Ms. Crissy Buchanan Carlisle Chief Financial Officer Mr. Ronald L. Langham Jr., M.B.A., P.T. Executive Vice President of Clinical Excellence & Strategy Ms. Jeanne Kalvaitis B.S.N., R.N. Executive Vice President of Hospice Operations Ms. Julie Diane Jolley B.S.N., R.N. Executive Vice President of Home Health